Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

NCT04564053 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Knee

Interventions

DRUG: LNA043
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals